STOCK TITAN
  1. Home
  2. Sec-filings
  3. ARTL
  4. [8-K] Artelo Biosciences, Inc. Reports Material Event

[8-K] Artelo Biosciences, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ARTL logo
Artelo Biosciences Inc

NASDAQ:ARTL

ARTL Rankings

#6335 Ranked by Market Cap
N/A Ranked by Dividends

ARTL Latest News

Oct 1, 2025
Artelo Biosciences Announces Closing of $2.0 Million Public Offering
Sep 30, 2025
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering
Sep 29, 2025
Artelo Biosciences Announces Proposed Underwritten Public Offering
Sep 29, 2025
Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference
Sep 10, 2025
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

ARTL Latest SEC Filings

Oct 3, 2025
[SCHEDULE 13D/A] ARTELO BIOSCIENCES, INC. SEC Filing
Oct 1, 2025
[424B5] ARTELO BIOSCIENCES, INC. Prospectus Supplement (Debt Securities)
Sep 30, 2025
[424B5] ARTELO BIOSCIENCES, INC. Prospectus Supplement (Debt Securities)
Sep 30, 2025
[424B5] ARTELO BIOSCIENCES, INC. Prospectus Supplement (Debt Securities)
Sep 19, 2025
[SCHEDULE 13D] ARTELO BIOSCIENCES, INC. SEC Filing

ARTL Stock Data

7.50M
1.25M
0.33%
1.58%
1.68%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOLANA BEACH